The sample copy of this report is available for access.
The LAMEA Mammography Market is expected to reach USD 591.4 million by 2029, growing at a CAGR of 7.3% during (2026 - 2033).
The LAMEA Mammography Market evolved from limited analog X-ray breast imaging concentrated in major urban healthcare centers into a progressively digitized diagnostic ecosystem. Adoption expanded as public health initiatives, cancer awareness programs, and healthcare modernization strengthened demand for earlier breast cancer detection. The transition toward digital mammography improved image quality, diagnostic accuracy, and workflow efficiency, while computer-aided detection and digital breast tomosynthesis further enhanced interpretation capabilities. More recently, artificial intelligence, tele-radiology, portable imaging systems, and advanced digital platforms have widened access and supported more precise breast imaging across geographically diverse healthcare environments.
Artificial intelligence, tele-radiology, mobile screening, digital mammography, and localized diagnostic solutions are shaping current market development. AI-assisted image analysis supports earlier lesion identification, risk assessment, and workflow efficiency where radiologist availability is limited, while tele-radiology enables specialist interpretation across remote areas. Portable and mobile mammography systems are expanding screening beyond metropolitan centers and improving access among underserved populations. Continued modernization of digital imaging infrastructure, localized equipment manufacturing, regulatory quality initiatives, training programs, and growing emphasis on personalized diagnostic approaches are also strengthening mammography capabilities across LAMEA.
Based on Service, the market is segmented into Screening, Diagnostic, and Interventional. The Screening market dominated the LAMEA Mammography Market by Service in 2025, and would continue to be a dominant market till 2033; thereby, achieving a market value of USD 357.8 million by 2029, growing at a CAGR of 6.8 % during the forecast period. The Diagnostic market is expected to witness a CAGR of 7.6% during (2026 - 2033). The Interventional market is expected to witness a CAGR of 8.9% during (2026 - 2033).
Screening mammography supports routine breast imaging among asymptomatic populations through organized programs, public health campaigns, mobile units, and community outreach. Diagnostic mammography provides targeted evaluation for symptomatic patients, suspicious screening findings, palpable abnormalities, and other clinical concerns through advanced imaging and detailed interpretation. Interventional mammography supports stereotactic biopsy, lesion localization, tissue sampling, and other image-guided procedures requiring specialized equipment and expertise. Digital mammography, AI-assisted interpretation, telemammography, improved referral pathways, and expanding breast-care infrastructure are influencing adoption across all three service categories.
Based on Imaging Modality, the market is segmented into 2D Digital, 3D Digital Breast Tomosynthesis, Contrast-enhanced, and Other Imaging Modality. The 2D Digital market dominated the LAMEA Mammography Market by Imaging Modality in 2025, and would continue to be a dominant market till 2033; thereby, achieving a market value of USD 251.8 million by 2029, growing at a CAGR of 6.6 % during the forecast period. The 3D Digital Breast Tomosynthesis market is expected to witness a CAGR of 7.4% during (2026 - 2033). Additionally, The Contrast-enhanced market is expected to witness highest CAGR of 8.4% during (2026 - 2033).
2D Digital mammography remains a foundational modality because of its accessibility, established clinical protocols, and relatively lower implementation requirements. 3D Digital Breast Tomosynthesis provides sectional breast imaging that improves lesion visibility and reduces tissue overlap, with adoption concentrated across private hospitals and advanced diagnostic facilities. Contrast-enhanced mammography provides additional functional information for lesion characterization and complex diagnostic assessment, particularly in tertiary care environments. Other Imaging Modality includes dedicated breast ultrasound, positron emission mammography, hybrid systems, and other specialized approaches used to complement conventional mammography for dense breast tissue and selected high-risk cases.
Based on End-User, the market is segmented into Hospitals, Specialty Clinics, Diagnostic Centers, and Other End-User. Hospitals provide integrated screening, diagnostic imaging, biopsy support, oncology coordination, and advanced breast imaging services within multidisciplinary healthcare environments. Specialty Clinics focus on breast and women’s health through targeted screening, diagnostic assessment, personalized consultations, and outpatient services.
Diagnostic Centers emphasize rapid outpatient imaging, high patient throughput, digital workflows, and tele-radiology connectivity. Other End-User includes mobile screening units, community health initiatives, private practices, nonprofit programs, and public outreach services that expand mammography access across rural, remote, and underserved populations.
Free Valuable Insights: Mammography Market Size Worth USD 10.0 Billion billion by 2033
Based on Country, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA. The Brazil market dominated the LAMEA Mammography Market by Country in 2025, and would continue to be a dominant market till 2033; thereby, achieving a market value of USD 153.8 million by 2029, growing at a CAGR of 6 % during the forecast period. The Argentina market is expected to witness a CAGR of 7.9% during (2026 - 2033). Additionally, The UAE market is expected to witness a CAGR of 6% during (2026 - 2033).
Across LAMEA, mammography adoption is being shaped by digital imaging, AI integration, mobile screening, tele-radiology, regulatory modernization, and expanding breast cancer awareness. Brazil emphasizes AI-assisted workflows, decentralized screening, mobile mammography, and quality standardization, while Argentina focuses on telemammography, AI-supported diagnostics, expanded screening access, and regulatory alignment. The UAE is advancing AI-enabled imaging, cloud-based infrastructure, digital breast tomosynthesis, and government-backed screening, whereas Saudi Arabia emphasizes AI-supported workflows, cloud imaging, dense-breast assessment, mobile screening, and healthcare modernization. South Africa focuses on digital mammography, AI integration, dense-breast imaging, mobile services, and broader accessibility, while Nigeria emphasizes community screening, digital modernization, tele-radiology, partnerships, and affordability. Rest of LAMEA continues to develop AI-enhanced interpretation, portable systems, public screening programs, low-dose digital imaging, and localized solutions for diverse healthcare settings.
By Service
By Imaging Modality
By End-User
By Country
Set to reach $591.4 Million by 2029, growing at 7.3% CAGR during 2026-2033.
Brazil leads with $153.8 million by 2029, growing at a 6% CAGR during the forecast period.
Rising demand for interventional services with an 8.9% CAGR during 2026-2033.
Screening segment to reach $357.8 million by 2029, growing at a 6.8% CAGR during the forecast period.
Expected to witness a 7.4% CAGR during 2026-2033.
Argentina market is expected to witness a 7.9% CAGR during 2026-2033.
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 